Podcasts about Meds

Constipation isn't just uncomfortable—it can become dangerous. Especially after illness, surgery, or certain medications, what seems minor can turn into something serious.In this episode, we explain what constipation is, why it happens, and what your body needs to function the way it should. We break down the role of hydration, movement, and fiber, and why small changes can prevent bigger problems.We also talk about who is most at risk, including people with chronic illness, those recovering from abdominal surgery, and anyone taking medications that slow the gut. https://bit.ly/3QEeoRSKey Moments:00:00 - Intro: The High-Risk Gut (Surgery, Aging, and GLP-1 Meds)01:33 - Fiber-lous Recipe: Spicy Deviled Walnuts02:04 - From Berated Brother to Breakfast Boss: The W.K. Kellogg Story06:11 - Adhesions and Bowel Obstructions, Why Abdominal Surgery Can Cause Constipation 07:29 - Secrets of a Good Movement: Roughage, Hydration, Exercise and Laxative Safety12:49 - "Thinker" on the Throne: Why Your Pooping Posture Matters15:14 - Want to Avoid Constipation? Eat This23:03 - Outro#constipation #guthealth #digestivehealth #bowelhealth  #fiber #hydration #healthtips #wellness #caregiverlife #endoflife #seriousillness #postoperativecare #nurselife #patienteducation #everyonediespodcast #cancersurvivor #aging #cancersurvivorSupport the showConnect with Us: Email our Host: mail@every1dies.org  Website: https://every1dies.org: Find show notes, links and expanded resources Follow Us: Facebook | Instagram | YouTube  

Pain can keep you doing what you love and ruin your quality of life. Hear an expert discuss a wide range of pain treatments, including some you might not have heard of. *Visit the Live Yes! With Arthritis Podcast episode page to get show notes, additional resources and read the full transcript: https://www.arthritis.org/liveyes/podcast/episodes/pain-relief-arthritis-155 * We want to hear from you. Tell us what you think about the Live Yes! With Arthritis Podcast. Get started by emailing podcast@arthritis.org.Special Guest: Yawar Qadri, MD, PhD.

GLP-1s like Ozempic and Wegovy are all over the news and TV ads lately. Are they really a safe way to lose weight? Racquel Williams talks with medical professionals from Penn Medicine's Center for Weight and Eating Disorders about the benefits and risks of GLP-1s, plus how social media impacts body image and how mental health is connected to food. Then, Philly Pride is bigger than ever this year! Shara Dae Howard hits up the kickoff event at Sofitel Philadelphia to find out what's going on all month - including a performance by Patti LaBelle - and how the LGBTQ+ community feels about the Pride festival moving from the Gayborhood to the Ben Franklin Parkway.

Can a simple blood test predict Alzheimer's before symptoms start? Is pink noise the secret to a better night's sleep? Join Tanner, Dr. Miles, and Jade (Mortal Kombat warrior?) for another breakdown of the latest headlines in medicine and health science. In this episode, we're diving into three fascinating updates you can actually use to improve your daily life: A Major Leap in Alzheimer's Screening: We discuss a new, highly accessible, and affordable blood test that is changing the game for early detection. The Color of Sound: You've definitely heard of white noise, but we look at why pink noise might be the superior option for deeper, more restorative sleep. Or maybe it's not! Beyond Antibiotics: We all know how antibiotics disrupt the gut microbiome, but new research shows that common medications (including popular diabetes and high blood pressure drugs) can also dramatically alter your gut health for better or worse. At HFWDM, we do the heavy lifting in the deep waters of medical research so you don't have to. Our goal is to bring you cutting edge and peer-reviewed science in a way that is easy to understand, practical, and entertaining. Have a question or a topic you want us to cover? We want to hear from you! Drop us a line at questions@healthfilesradio.com. Just a few of the resources used with this episode: Efficacy of pink noise and earplugs for mitigating the effects of intermittent environmental noise exposure on sleep https://academic.oup.com/sleep/advance-article/doi/10.1093/sleep/zsag001/8452884?searchresult=1&login=false Drugs Can Reshape Your Patient's Gut — Sometimes for Years A hidden confounder for microbiome studies: medications used years before sample collection https://pubmed.ncbi.nlm.nih.gov/40910778/#article-details Impact of Early Alzheimer's Diagnosis on Treatment of Cognitive Decline. Dr Paul Rosenberg, of the Johns Hopkins University School of Medicine video interview.

Many of you may have heard me talk about the impact of brain development on behavior in different life stages (if not, check out my TEDX Talk - link below).  Well, dopamine is in all of us - do you know it is intricately connected with "rewards"?  And CBT is intricately connected to dopamine.Are we seeing a symbiotic relationship?  Check out this episode where we get the dope on dopamine.Be sure to sign up to our email list on the website, and check out the new program structure and pricing options.My TEDX Talk is live!  Beyond Dog Training: The Movement Toward Sentiencehttps://youtu.be/avUugazybwcFind all the episodes on Feedspot, where Dog Training DisrUPted is rated in the top 5 shows in the dog category in Canada:  https://blog.feedspot.com/canadian_dog_podcasts/To become a certified Canine CBT Psychotherapist, and for courses on related topics, please visit the Institute of Canine Psychotherapy. www.instituteofcaninepsychotherapy.comBecome a Certified Canine Behaviorist and Dog TrainerMy Linktree with all my media, presentations, shows, articlesBillie Groom - UPWARD Dogology | Instagram, Facebook | LinktreeHere is the link to the recent article in Psychology Today Mag by Marc Bekoff on Canine CBTDog Training: Perception, Cognition, and Emotions | Psychology TodayBuy My Book! Winner of the 2019 American Best Book Fest Award (pets/narrative/non-fiction)The Art of Urban People With Adopted and Rescued Dogs Methodology: Rescued Dogs: The Misunderstood Breed: Groom, Billie: 9781525547287: Books - Amazon.ca

In this episode of Mind the Meds, Erica Marini, PharmD, highlights information from the European Stroke Organization Conference include encouraging data on asundexian(Bayer), a factor XIa inhibitor showing reduced recurrent ischemic stroke risk without increased bleeding, as well as positive results from three trials of tirofiban in acute ischemic stroke settings. On the multiple sclerosis (MS) front, Marini covers the FDA approval of ocrelizumab (Ocrevus; Genentech) for pediatric relapsing-remitting MS in children 10 and older, a new study supporting early use of high-efficacy agents in pediatric MS, and 2 Lancet publications on ocrelizumab — one examining higher weight-adjusted dosing (which did not improve disability progression) and one confirming benefit in a broader primary progressive MS population. She also briefly discusses PADOVA (NCT04777331), a phase 2b trial of prasinezumab in early Parkinson's disease, which failed to meet its primary end point.The bulk of the episode is a discussion with guest Millad Sobhanian, PharmD, BCPS, clinical pharmacy specialist in neurology at the University of Maryland, focused on Alzheimer disease. They cover dextromethorphan/bupropion (Auvelity; Axsome Therapeutics), newly approved in April 2026 for agitation associated with Alzheimer dementia. Sobhanian walks through key safety considerations—including additive NMDA antagonism if combined with memantine, cardiovascular risks from the bupropion component, and the ever-present black box warning on antipsychotics in dementia patients—while both note that the efficacy data, though statistically significant, shows modest clinical effect sizes compared to the threshold for meaningful within-patient change.The conversation then turns to lecanemab's subcutaneous initiation formulation (Leqembi Iqlik; Eisai, Biogen), whose FDA decision has been delayed to about August 2026 as regulators seek more data on bioavailability and ARIA monitoring in the at-home setting. Sobhanian shares his real-world perspective on anti-amyloid therapy, describing a patient population that is typically early-stage, high-functioning, and has a mean age of about 60 to 70 years, and emphasizing the pharmacist's role in expectation-setting around the modest but potentially cumulative slowing of cognitive decline. The episode closes with a thorough discussion of the April 2026 Cochrane review on amyloid-targeting monoclonal antibodies, which both Marini and Sobhanian find overly broad in its conclusions. They note limitations such as the inclusion of withdrawn agents like aducanumab (Aduhelm; Biogen), heterogeneous inclusion criteria across trials, and an 18-month study horizon that may be too short to capture the full benefit suggested by longer-term open-label extension data.Key Takeaways:1. New options for Alzheimer's agitation exist, but fit carefully into the treatment algorithm. Dextromethorphan/bupropion offers a novel NMDA-based mechanism for treating agitation in Alzheimer dementia, but its clinical effect size is modest, and it carries meaningful safety considerations—particularly around the bupropion component in elderly patients. Like all pharmacologic options in this space, it remains a later-line choice after nonpharmacologic interventions have been exhausted, and medication reconciliation is critical given its interaction potential with memantine and CYP2D6 inhibitors.2. Anti-amyloid therapies are imperfect but not ready to be written off. The April 2026 Cochrane review drew significant attention with its conclusion that anti-amyloid monoclonal antibodies produce only trivial cognitive benefits, but its findings are limited by the inclusion of older, withdrawn agents, heterogeneous trial populations, and an 18-month time horizon that may be too short to capture the full trajectory of benefit.3. The pharmacist's role in anti-amyloid therapy goes well beyond dispensing. As illustrated by Sobhanian's practice at the University of Maryland, clinical pharmacists embedded in neurology clinics play a critical role in patient selection, expectation-setting, ARIA counseling, and informed decision-making for patients considering anti-amyloid therapy—a complex, high-stakes treatment decision that these patients and their caregivers should never be navigating alone.

Send Zorba a message!More good news for coffee drinkers: Zorba digs into new research showing drinking 2-3 cups of coffee per day may help fend off dementia risk. Zorba helps a listener who asks why it's so difficult to obtain her monthly ADHD medication. He weighs in on why some doctor exams can lead to extraneous billing. We hear a Disney-centric Mom Joke, and scroll through some listener comments from the Facebook page.Support the showProduction, edit, and music by Karl ChristensonSend your question to Dr. Zorba (he loves to help!):Phone: 608-492-9292 (call anytime)Email: askdoctorzorba@gmail.comWeb: www.doctorzorba.orgStay well!

Send Zorba a message!More good news for coffee drinkers: Zorba digs into new research showing drinking 2-3 cups of coffee per day may help fend off dementia risk. Zorba helps a listener who asks why it's so difficult to obtain her monthly ADHD medication. He weighs in on why some doctor exams can lead to extraneous billing. We hear a Disney-centric Mom Joke, and scroll through some listener comments from the Facebook page.Support the showProduction, edit, and music by Karl ChristensonSend your question to Dr. Zorba (he loves to help!):Phone: 608-492-9292 (call anytime)Email: askdoctorzorba@gmail.comWeb: www.doctorzorba.orgStay well!

In this episode of Mind Your Own Karma – Beyond theBandage, I sit down with Dr. Fawad Mian, a board-certifiedneurologist, regenerative medicine specialist, and founder of Vitality Integrative Wellness, to challenge one of the most common narratives around aging and pain—that chronic pain after 50 is inevitable and must be managed with medications or surgery. After experiencing multiple injuries himself and being toldthose were his only options, Dr. Mian chose a different path. Through regenerative therapies like PRP and stem cells, combined with detailed diagnostics and a unique approach to re-movement, he healed his own body—and built a practice centered on helping others do the same. This conversation is for anyone who feels dismissed, rushed,or stuck in the cycle of symptom management. We talk about why pain becomes chronic, what's often missed in traditional care, and how the body's capacity to heal doesn't simply disappear with age.What you'll learn in this episode:Why chronic pain is not “just part of getting older”How regenerative medicine works at the tissue and nervous system levelWhat PRP and stem cell therapies actually do inside the bodyHow Dr. Mian evaluates the root cause of pain, not just where it hurtsWhat re-movement is and why exercise alone often isn't enoughHow to know if regenerative medicine may be right for youThe questions to ask so you can make informed, confident decisionsWhy hope and healing are still possible well beyond 50Where to find Dr. Fawad Mian:Website: https://prolohealing.com/Website: https://www.advocareneurowellnessmd.com/YouTube: https://www.youtube.com/@prolohealingLinkedIn: https://www.linkedin.com/in/fawad-mian-40aaaa150/Instagram: https://www.instagram.com/prolohealingmedspa/Book: Getting to Pain Free: How to Make Your Body Stop Hurting So You Can Start Living Without Drugs or Surgeryhttps://www.amazon.com/dp/B0D46W27T5FIND MELISSAON WEBSITES:⁠https://www.somatichealingjourneys.com⁠⁠https://www.mindyourownkarma.com⁠ON SOCIALSMYOK on Instagram:⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/mind_your_own_karma⁠⁠⁠⁠⁠⁠⁠⁠⁠MYOK on Facebook:⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/mindyourownkarma⁠⁠⁠⁠⁠⁠⁠⁠MYOK on YouTube:⁠⁠⁠⁠⁠⁠https://www.youtube.com/@MindYourOwnKarma⁠⁠This episode is for educational purposes only and is notintended as medical advice.#MindYourOwnKarma #SomaticMindfulGuidedImagery #SMGI #SomaticHealingJourneys #RegenerativeMedicine #ChronicPainRecovery #StemCellTherapy #PRPTherapy #NeurologyMeetsHealing #HealingWithoutMeds #MovementReeducation #PainFreeLiving #Over50AndThriving#AlternativeHealingModalities #RootCauseHealing #HighPerformanceHealing #HolisticNeurology #DrFawadMian #MindBodyMedicine #PainIsNotYourNormal #ChronicPain

In this episode, we break down the science behind GLP-1 medications including Ozempic, Wegovy, Zepbound, Mounjaro, semaglutide, and tirzepatide. Learn how GLP-1 weight loss medications work, their role in appetite suppression, insulin regulation, metabolic health, obesity treatment, and type 2 diabetes management.This evidence-based discussion explores GLP-1 benefits, side effects, muscle loss concerns, weight regain after stopping medication, nutrition considerations, digestion, metabolic adaptation, and sustainable wellness strategies. If you're considering GLP-1 medications or simply want a smarter conversation about obesity medicine, weight loss, longevity, and metabolic health, this episode delivers a clinically grounded wellness perspective. Disclaimer: This podcast is for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. The views shared are intended to support informed wellness conversations and should not replace individualized guidance from your physician or qualified healthcare provider. Always consult your healthcare team before making decisions regarding medications, treatment, nutrition, or health management.

This scripture is perfect for sleep and meditation. I'm so grateful that my friends are listening to this. The back ground flutes is Spotify's R. Carlos Nakai Radio

What happens when the "perfect student" is actually drowning? 0:00 – Trailer0:42 – Intro: Faith. No Filter.4:20 – Secret signs of ADHD in kids8:36 – Beyond the bell curve: defining "normal"12:44 – School “discipline” and neurodiversity17:43 – Meds & masking: why girls fall under the radar21:33 – Are churches safe for neurodiversity?25:36 – Traditions of misjudgement28:52 – Who is responsible for inclusion?33:56 – “I see you” and the culture of true belonging36:13 – Closing thoughts on hope and radical kindnessIn this episode of Filthy Hope, hosts Rev Ness Williams-Henke and Rev Jon Humphries continue their conversation with Lynda Humphries, this time diving into neurodiversity: what it actually means, why ADHD has been so misunderstood, and what genuine inclusion looks like in schools, workplaces, and faith communities.Lynda shares her family's personal journey with ADHD, unpacking why girls so often go undiagnosed, what educators can do differently, and why the church needs to move well beyond tolerance. They argue that the burden of adjustment shouldn't fall on those who are already struggling, but on those in the "easier space" to create a culture where everyone can truly belong.#FilthyHope #ChristianPodcast #Neurodiversity #ADHD #InclusionMatters #ChurchAndNeurodiversity #ChurchCulture #FaithAndMentalHealth #BeyondTolerance #FaithNoFilter

Welcome back, everyone. Today we're diving into one of the most hotly debated topics in obstetrics- should we be treating preeclampsia without severe features with antihypertensive medications during expectant management? Now, if you've been following the literature- and our show, you know that the landmark CHAP trial changed the game for chronic hypertension in pregnancy. It showed us that targeting a blood pressure below 140 over 90 reduces serious maternal complications, without harming the baby. That was a big deal. But here's the thing, CHAP studied chronic hypertension. Then there was the CHIP trial- that also found that tight control of gestational hypertension and nonproteinuric chronic hypertension was also beneficial. These did not address preeclampsia without severe features, and yet, the ripple effects of that trial have sparked a global conversation about whether we should be extending those same treatment principles to women with preeclampsia who don't yet have severe features. And this is where it gets really interesting, because the guidelines don't agree. In the United States, ACOG and the Society for Maternal-Fetal Medicine still say: hold off on antihypertensives unless blood pressures hit the severe range at 160/110. But step outside the US, and you'll find the World Health Organization, the International Society for the Study of Hypertension in Pregnancy, FIGO, NICE, and Hypertension Canada all recommending treatment at 140 over 90, regardless of whether the diagnosis is chronic hypertension, gestational hypertension, or preeclampsia. So who's right? And more importantly what does this mean for the patient sitting in front of you right now, at 34 weeks, with a blood pressure of 150 over 95, some proteinuria, but no severe features? Today, we're going to break this down. We'll review the controversy, walk through the divergent guidelines, and most importantly talk about the real, practical implications that favor treating these patients during expectant management. Because when you're watching someone with preeclampsia, waiting for the right time to deliver, there's a strong argument that controlling their blood pressure isn't just reasonable…may be protective. So grab your coffee, settle in, and let's get into it.1. Society for Maternal-Fetal Medicine Statement: Antihypertensive Therapy For mild chronic Hypertension in Pregnancy-The Chronic Hypertension And Pregnancy Trial. American Journal of Obstetrics and Gynecology. 2022. Society for Maternal-Fetal Medicine; Publications Committee. 2. Preeclampsia. The New England Journal of Medicine. 2022. Magee LA, Nicolaides KH, von Dadelszen P.3. Antihypertensive Drug Therapy for Mild to Moderate Hypertension During Pregnancy.The Cochrane Database of Systematic Reviews. 2018. Abalos E, Duley L, Steyn DW, C.4. Prevention and Treatment of Maternal Stroke in Pregnancy and Postpartum: A Scientific Statement From the American Heart Association. Stroke. 2026. Miller EC, Bello NA, Chen PR, et al.5.Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association. Hypertension. 2022. Garovic VD, Dechend R, Easterling T, et al.

The Commitments (1991) Welcome to this months episode in which Meds and Kell very much waffle on about this brilliant Alan Parker film. Released in October 1991 the film launched the careers of several actors especially the brilliant Andrew Strong who was only 16 at the time of filming.  As always please do share our podcast and leave a review.  

https://www.instagram.com/reel/DYP4s9fvohV/

If I couldn't, or didn't want to, take ADHD medication, how would I support my brain?In this episode, I'm walking you through exactly how I'd approach ADHD treatment without meds. This is not anti-medication content. Medication helps me tremendously. But many people don't have access, don't tolerate it well, or simply don't want to take it. You still deserve support.We're talking about what actually helps ADHD brains function: external support, nervous system regulation, movement, sunlight, sleep, structure, accountability, relationships, and designing a life that works with your brain instead of against it.I share what I'd invest in if I had financial resources, like coaching, meal support, cleaning help, therapy, and body doubling, and what I'd focus on if I had zero extra money.Because treatment isn't just medication. It's how you structure your environment, care for your nervous system, fuel your body, and build support around you.You are not powerless. ADHD support is built, not found.Watch this episode on YouTubeWant help with your ADHD? Join FOCUSED!Have questions for Kristen? Call 1.833.281.2343Hang out with Kristen on Instagram and TikTokSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

How is it we're still stuck with the same ole - same ole for ADHD meds? Well, good news - this July, ADHDers in the US might have access to a new medication that not only helps with ADHD, but can also help with common comorbid conditions - Anxiety and Depression. Tune in to hear about this new medication, Garet's new guinea hen (and baby?) adventures, and Katie's frustration with car shopping, because the bar is ankle high. Don't forget to leave us a 5-star review anywhere you find our podcast and follow us on social media!Sources: https://www.otsuka-us.com/news/otsuka-announces-fda-acceptance-and-priority-review-new-drug-application-centanafadine

What if the most powerful tool for mental health recovery isn't a medication — it's your metabolism?  Dr. Erin Louise Bellamy joins Dr. Vera Tarman for a deep dive into ketogenic metabolic therapy: what it is, how it works, and why it may be one of the most underutilized interventions in both psychiatric care and food addiction recovery.  Dr. Bellamy is a chartered psychologist, CEO of IKRT (International Ketogenic Research & Therapy), and a research fellow at the University of East London. She has been researching and applying ketogenic metabolic therapy in clinical settings since 2014, with a background that bridges eating disorders, psychiatric research, and metabolic health.  In this episode, Vera and Erin discuss:  How Erin went from eating disorder and alexithymia research to ketogenic metabolic psychiatry — and why the field's "biopsychosocial" model was missing the bio  The difference between metabolic psychiatry, ketogenic therapy, and therapeutic carbohydrate restriction — and why the terminology matters  What carbohydrate range actually produces therapeutic ketosis (and why "dirty keto" doesn't cut it)  The shared mechanistic pathways across psychiatric diagnoses — including mitochondrial dysfunction, insulin resistance, and neuroinflammation  Why antipsychotic medications create metabolic dysfunction, and how ketogenic therapy can help offset those side effects  The GABA/glutamate shift that makes ketones naturally anxiolytic — and why this may work differently than the serotonin model of depression  The "buffer effect": what it feels like to be in ketosis when you're a food addict — and why some people describe it as a pane of glass between themselves and a trigger food  How ketogenic therapy compares to GLP-1 medications (Ozempic/Wegovy) for reducing food noise — and Erin's concerns about the long-term research  MCT oil vs. exogenous ketones: when each is useful, and when exogenous ketones are counterproductive  Applying ketogenic therapy to people with ADHD, bipolar disorder, and co-occurring food addiction  How to support vegan or plant-based clients who want to pursue ketogenic therapy  Why the first week matters most — and how to help clients through withdrawal without triggering a binge  The 19-person IKRT group program published in Frontiers — and what's coming next in the research  Connect with Dr. Erin Bellamy:  

If you've done the therapy, set the boundaries, and still find your body holding onto stress, symptoms, or chronic issues, this episode will shift how you understand healing entirely.In this conversation, Dr. Kelly Kessler sits down with Marcus Fernandez, a global leader in homeopathic education and Principal of the Centre for Homeopathic Education, to explore what it really means to heal at the root—not just manage symptoms.Marcus shares how a personal health experience led him from a completely conventional path into natural medicine, and why true healing isn't about fixing the body—it's about activating the intelligence already within it. Together, they unpack:Why so many high-achieving women still feel unwell even after “doing the work”The difference between symptom suppression and true root-cause healingHow homeopathy works (and why it's more individualized than conventional approaches)The hidden ways we've been conditioned to give our health power awayThe 4 foundational pillars (MEDS framework) that create real, sustainable wellnessWhy your body already knows how to heal and what blocks that processThis episode is not about rejecting modern medicine. It's about becoming informed, empowered, and deeply connected to your own body again.If you've been overriding your body for years…This conversation will show you a different way back.Marcus Fernandez has been at the forefront of homeopathic education for over three decades. As Principal of The Centre for Homeopathic Education (CHE), he's trained thousands of practitioners through a curriculum that balances classical knowledge with modern application. His work is rooted in a belief that natural medicine should be practical, empowering, and accessible - not mystified or gatekept.His latest book 'Homeopathy at Home' reflects that ethos. Designed to be used, not shelved, it offers simple, step-by-step guidance for everyday ailments using natural remedies. Its success, reaching #1 in Amazon's holistic medicine category, reflects a rising demand for family-focused, self-directed wellness. Marcus also created an AI-powered virtual assistant that lets people ask home prescribing questions 24/7 - a project born from his desire to make quality natural health advice as available as online misinformation.While his formal background is in homeopathy, Marcus speaks just as comfortably about men's health, slow living, and holistic longevity. He co-hosts Beyond the Shed, a raw and reflective podcast spotlighting unfiltered conversations about men's emotional health — part of a wider mission to create space for honesty, healing, and ownership in the way we care for ourselves and each other.Whether he's teaching herbal remedies in a London classroom or exploring health span strategies on a podcast, Marcus brings curiosity, compassion, and depth to every conversation. His message is clear: the body already knows how to heal — we just have to give it the right tools. Marcus' warmth and wisdom makes natural health both useful and deeply human.Connect with Marcus:https://www.youtube.com/@Homeopathy-at-Homehttps://marcus-fernandez.com/https://www.linkedin.com/in/marcus-fernandez-98252523/https://www.instagram.com/marcusfndez/https://www.facebook.com/people/Marcus-Fernandez/100009253627766/?skhttps://www.amazon.co.uk/Homeopathy-Home-Everyday-Treatments-Complaints/dp/1837823189

Send us Fan Mail

You're trying to focus on your work, but that bag of sea salt chips in the pantry is practically shouting your name. You try to ignore it, but five minutes later, you're standing in the kitchen with the lid off the ice cream, wondering why you can't just stop thinking about it. If you know, you know... that relentless mental chatter. If you've tried to quiet this noise in the past and struggled, you were likely fighting an unknown cause: internal programming that most diets completely ignore. Most people don't realize that this chatter isn't a lack of willpower; it's a physiological response that can be rewired at the source.In this episode, we're tackling it head-on. As you discover the 3 pillars to reclaiming your mental freedom, you'll quickly begin to realize what it's like to live without food being the main character of your internal monologue: Stabilizing hunger hormones so your body stops sending you into a spiralEnhancing satiety both physical and psychological, because restriction alone will never workRewiring your brain using neuroscience-based techniques to change how you respond to cravings at the sourceYou'll also hear why GLP-1 medications alone aren't the full answer, the "Yes And" technique for breaking the all-or-nothing cycle, and why managing stress isn't always about meditation, sometimes it means making the hard calls.This isn't another restrictive diet tip. This is about updating your internal programming so you can navigate food, and life, with real, lasting confidence.P.S. I know you're busy, so mark June 8th on your calendar now. That's when our immersive 5-day experience begins, and we'll start the rewiring process for good. Don't even think about starting another diet until you've experienced this. Did you enjoy the episode?  DM me on instagram and let me know what you thought. 

Health/lifestyle consultant, 14-year carnivore and drummer Phil Escott got chronically ill as a vegetarian, and his body revolted with psoriatic arthritis and other autoimmune conditions in 2010, leaving him unable to move without severe pain, let alone drum or exercise, and he had to throw out all his existing “expertise” and start from scratch. Phil's eventual combination of a carnivore diet with EMF and artificial light avoidance, cold thermogenesis and a range of other health enhancing practices reversed the “incurable” diseases that he suffered from. His book “Arthritis, The Best Thing That Ever Happened to Me” gained a foreword by Dr. Jack Kruse and has become an Amazon Kindle bestseller and is now available in print. Phil talks from personal experience about contemporary lifestyle and diet choices, disconnects from our ancestral heritage, emotional balancing and the simple but often misunderstood nature of spiritual awakening. He now consults with clients worldwide helping them to reverse their metabolic and autoimmune issues and runs The Big Fat Challenge with Ben Hunt as his main project. His latest book, the "Red Pill Revolution" is awesome. Melissa Lim is a Canadian American Pharmacist and volleyball player/enthusiast. She was inspired by a previous episode with "meat militia" member Phil Escott and leader Dr Bart Kay. Her journey on completely overhauling her diet has had life changing results, from getting rid of Acne she has had since age 9, to an energy level and clarity that is shooting through the roof. The chronological path of paying it forward continues. 02:39 - Melissa's journey to carnivorism, the ailments the journey, the right path, Phils tells his journey of the same that led to his first book 26:23 - Why carnivorism is now a growing culture, not a diet but a species appropriate way of life, how to maintain sources of vitamin C, discussing the notion that athletes "need" carbohydrates or not, the glycemic chart and how to use it 39:33 - Having the difficult discussion with loved ones on the benefits or health changes, perhaps best to lead by example and show the results, first-hand, understanding that the opposition is not monolithic, the division between the stubborn, the willfully ignorant, and how the sales pitch can help people or turn them off 50:01 - Getting rid of foods that are addictive and diminishing your quality of life, who needs this more than most and how to help 1:12:33 - The silly notion of this being a "grift" (the censorship, the loss of reputation, the amount of work being done for free), the perfect "stool" lol, the attack by General Mills on our breakfast index, and why none of it was scientific 1:23:42 - Meds that help and meds that kick the can down the road, the leaky gut, inflammation, HDL and LDL and how people misinterpret it, what you are being told to do, vs the one who has to live with the results (you), plus, what feeds the gut Biome? 1:37:39 - HDL and LDL and how people misinterpret it, seed oils, and throwing away the meat for the sins of the bun, plus, new events, retreats, seminars and getaways

See omnystudio.com/listener for privacy information.

US News and World Report releases their annual best over-the-counter products list; new guidance for drug safety evaluation during pregnancy; gMG indication broadened for efgartigimod; Beqalzi gains accelerated approval for MCL; and a novel treatment fast tracked for ALS.  

Could the "weight-loss shots" everyone is talking about actually be the next big breakthrough in cancer prevention? In this week's episode of the FMI podcast, I'm joined once again by our Chief Medical Officer, Dr. Mark Holthouse. While Dr. H is a world-renowned expert in hormone health and cardiometabolic medicine, today we are diving into a topic that is reshaping the future of longevity: the direct link between obesity-related cancers and GLP-1 medications. We recently learned that colon cancer is now the leading cause of cancer death for men and women under 50. It's a sobering statistic, but there is hope in the evolving science of metabolic medicine. In this episode, we discuss: The "Four Horsemen" of Aging: Why cardiovascular disease, cancer, dementia, and insulin resistance are all driven by the same cellular pathways. GLP-1s Beyond Weight Loss: How medications like Semaglutide and Tirzepatide work at the cellular level to potentially reduce tumor volume and progression. The "New Kid on the Block": A deep dive into Retatrutide, the experimental triple-agonist showing even more dramatic results in preclinical models. Obesity-Related Cancers: Why fatty liver, chronic inflammation, and nutrient-sensing pathways (like mTOR) create a "pro-cancer milieu." The "Foundational Four": Why, despite all the medical breakthroughs, sleep, clean eating, stress management, and exercise remain the ultimate levers for health. Dr. Holthouse also shares his "minimalist" approach to detoxification and why he's more interested in "reining patients in" from expensive gadgets to focus on what actually moves the needle. Whether you are interested in the latest longevity science or simply looking for ways to lower your family's risk of chronic disease, this conversation is packed with "root cause" insights you won't want to miss.

Website

SEASON 6 of Emetophobia Help TRIGGER WARNING: Words such as "vomit,” “throw up” and "sick" may be used. Host: Anna Christie, Psychotherapist and Emetophobia SpecialistGuest: Diana Haven11 Emetophobia CLASSES with Anna: www.emetophobiahelp.org/classesAnna's Book: Conquer Your Emetophobia on Amazon.comhttps://www.amazon.com/Conquer-Your-Emetophobia-Therapist-Overcame/dp/1805017764/ref=sr_1_1?crid=2D36DGAWBEPJK&dib=eyJ2IjoiMSJ9.Acbit8CAfkzOBj7DL2Nv78oGS9fkzCRJb6nA4jX1gRqcVDXuvBExOO90VyrVNBi3a1Ce-L5UlF0JqC076lWTnG5_SQQBUxYy04DI5eQHzssFPIZzniNfwRgipeT2V03g1q61jEZJ_-psTQEQesEST_LgQKjS6nkysXtI0PZrdF88ADoEakdiDk3PNVX0seLHpdQq04t9FXr1LWZNt9uL4ZXzJfVFykI0dJyqA4fWeeA.o285WUSMKi7F_7CB-OF_wrCZUXTzDGjMBatV1lTfadc&dib_tag=se&keywords=conquer+your+emetophobia&qid=1772144433&sprefix=Conquer+your+emet%2Caps%2C187&sr=8-1Facebook Group: Emetophobia NO PANICANNA & DAVID'S BOOK: Emetophobia: Understanding and Treating Fear of Vomiting in Children and Adults: Russ, David, Dr., Christie, Anna S., FOR KIDS: "Turnaround Anxiety Program" with Emetophobia supplement (McCarthy/Russ) and  Emetophobia! The Ultimate Kids' Guide eBook : Russ. PhD, DavidBuy Me a Coffeehttps://buymeacoffee.com/emethelpIntro Music: YouTube Audio Library, "Far Away (Sting)" by MK2, Used with Permission.Support the showAnna's Website: www.emetophobiahelp.orgResource site for Clinicians: www.emetophobia.netMERCH for stress, anxiety, panic: www.katralex.com

This inaugural episode of Mind the Meds introduces neurology pharmacy practice through a discussion between 3 neurology pharmacists working across inpatient and outpatient settings at the University of Utah. Host Erica Marini, PharmD, meets with her colleagues, Sarah Dahoney, PharmD, and Tyler Kenny, PharmD, BCCCP, both of whom are clinical pharmacists at the University of Utah Health, to discuss the research presented at the 2026 American Academy of Neurology (AAN) Annual Meeting. After sharing their diverse professional “origin stories,” the conversation then shifts to the role of pharmacists in neurology care and highlights key updates from the American Academy of Neurology annual meeting. The hosts discuss advances in neuromuscular disease, particularly myasthenia gravis, where emerging therapies such as FcRn inhibitors and CAR T-cell therapies are reshaping treatment paradigms. They also explore rare neurological conditions like stiff person syndrome and Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), where early-phase trials suggest promising but still preliminary therapeutic options. Finally, the episode reviews broader neurologic and systemic trends, including GLP-1 receptor agonists and SGLT2 inhibitors, noting potential but not yet definitive benefits in dementia prevention, stroke risk reduction, and migraine outcomes. Across all topics, the episode emphasizes the rapid evolution of neurological therapeutics and the expanding role of pharmacists in maneuvering complex, high-cost, and highly specialized treatments.Key Takeaways: Neurology pharmacy is highly collaborative and evolving, with non-linear career pathways. Pharmacists in neurology often enter the field through diverse experiences rather than a standardized training pipeline, and success depends heavily on adaptability, clinical curiosity, and initiative.  Pharmacists play a critical role in optimizing complex neurological therapies and care transitions. Their contributions span inpatient safety monitoring, outpatient medication access and affordability support, and ensuring continuity of care for high-risk, high-cost therapies.  Neurology therapeutics are rapidly advancing, but many emerging treatments remain early-stage. New therapies such as FcRn inhibitors, CAR T-cell approaches, and complement-targeting agents show promise across conditions like myasthenia gravis and rare neuroimmunologic diseases, while broader drug classes like GLP-1s are still under investigation for neurological benefits. 

In this powerful and deeply raw episode of Autism for Badass Moms, host Rashidah sits down with R.S. Cole, a 40-year-old mother of four from Houston, whose journey through autism parenting has been anything but ordinary.After her youngest son, J, was diagnosed with autism at just 2 years old, R.S. quickly realized the harsh reality many families face — a system that often falls short. Instead of accepting it, she chose to become the change. Driven by love and necessity, she became a Behavioral Therapist, dedicating her life to supporting families who, like her, were navigating a lack of resources and support.R.S. speaks with honesty and courage about the full spectrum of autism parenting — the structured, “good” days… and the incredibly difficult ones marked by defiance, destruction, medication side effects, and emotional exhaustion. Even now, as her son is 14, the fight for appropriate care and support continues.Beyond her lived experience, R.S. has transformed her pain into purpose. As a Holistic Practitioner with multiple certifications, she is the founder of A Beautiful Mind — a nonprofit and private community created to be a beacon of hope for families navigating life after a neurodiversity diagnosis.Her impact doesn't stop there.R.S. is also:`-Author of 14 books-Creator of a transformative course blending Behavioral Therapy, Metaphysics, and Energetic Healing-Currently in Clinical Admission for a renowned ABA therapy organization, using her voice and presence to push for meaningful changeIn this episode, we discuss: 00:00 Badass Moms Welcome00:40 Episode Topic CPS Trauma02:25 Meet RS Cole 04:10 Dog Talk05:54 Early Regression Signs07:11 Therapy Daycare Wake Up08:36 Home Support Breakthrough11:47 Diagnosis Delays System Gaps14:29 School Moves Behavior Escalation21:24 Day Treatment COVID Homeschool23:15 Medication Struggles Bestie Support28:08 School Pressure Door Visit31:05 CPS Well Check Shock33:00 False Report Debunked34:30 School Blocks Withdrawal35:08 Truancy Threats Escalate36:21 IEP Showdown With Backup39:29 Homeschool Reset and SSDI Tip41:03 ABA Aging Out and Texas Move42:24 Family Rally and Community Support45:19 Building NeuroSpirits Mission48:49 Protocols and Holistic Tools52:10 Caregiver Grief and Regulation56:45 Know Your Rights Advice01:00:26 Badass Wrap and CalloutsConnect with R.S. Cole:Instagram: www.instagram.com/holisticministriesWebsite: www.holisticministries.orgIf this episode resonated with you, don't forget to:-Follow the podcast-Subscribe on your favorite podcast platform-Leave a review to help us reach more autism moms across the globe-Share this episode with a mom who needs to hear thisInstagram: www.instagram.com/theabmpodcastFacebook: www.facebook.com/theabmpodcast

Mike Koop is a singer/songwriter who has played in such bands as The Bonaduces, Cheerleader, The Leftists, The Kicker, and Meds. He played guitar and sang in Dud. https://dudband1996.bandcamp.com/album/may-not-go-unrealized-recordings-from-1996

In this hour, former Penguin Tyler Kennedy comes on with Adam Crowley and Dorin Dickerson to react to the latest developments in the NHL playoff series between the Penguins and the Philadelphia Flyers. April 28, 2026, 9:00 Hour

New Schizo: Ring doorbell footage brings us a new schizo Harry Dresden (Jason Nichols) that is an all timer right off the jump.Jada Pinkett and Will Smith: Jada Pinkett continues to drag Will Smith in the name of her vague platitudes about being the driver of the boat or some shit.After Hours: Post show we get a call from Nick Rekieta hot off of his Jim and Them Hackamania reaction.THE BEAR!, FUCK YOU WATCH THIS!, MICHAEL JACKSON!, JUST LEAVE ME ALONE!, BAD!, VIVA LA BAM!, BEANIES WITH BRIMS!, SOUTH PARK!, CATCH UP!, SUPERTIPS!, SUPERCHATS!, COREY FELDMAN!, RING DOORBELL!, HARRY DRESDEN!, I WILL END YOU!, FREAK OUT!, CRASH OUT!, JASON NICHOLS!, MEDS!, PRIOR OFFENSES!, OPEN THE DOOR!, PREGNANT WIFE!, CHILD!, SHOVEL HIT!, HID IN THE GARAGE!, WEAPONS!, SPELL! CHLOE FINEMAN!, SNL!, PANTSED A YOUNG BOY!, CRAZY STORY!, THE DRAMA!, AWKWARD!, REACTIONS!, VANITY FAIR!, JADA PINKETT SMITH!, WILL SMITH!, WICKED WIZDOM!, HEAD BOB!, NU METAL!, BUTT ROCK!, FESTIVAL!, LOONEY TUNES!, RIDING IN THE CAR WITH THE OWL!, EAT A JELLYFISH!, STING!, JAY CASHMERE!, AI MUSIC!, NICK REKIETA!, DABBLEVERSE!, LORE!, INTERVIEW!, PUPPET!, AARON IMHOLTE!, POLYCULE!, AI SONGS!You can find the videos from this episode at our Discord RIGHT HERE!

SpaceX struck a deal giving it the option to acquire Cursor for $60B or pay $10B, as xAI scrambles to catch up in AI coding. Google unveiled new TPUs and an agent platform, OpenAI shipped ChatGPT Images 2.0, and Mythos got accessed by unauthorized users. SpaceX says it's working with Cursor to build "the world's most useful models" and it has the right to acquire Cursor for $60B or pay $10B for the partnership (NYT) Google unveils a new TPU lineup consisting of the TPU 8t for AI training and the TPU 8i for inference, with general availability scheduled for later in 2026 (Bloomberg) OpenAI releases ChatGPT Images 2.0 with new "thinking capabilities", allowing it to search the web to help it create multiple images from a single prompt (The Verge) Source: a handful of unauthorized users in a private Discord channel have been accessing Anthropic's Mythos model since the day the company announced it (Bloomberg) Meta is installing tracking software on US staffers' computers to capture mouse movements, clicks, and keystrokes in work-related apps for use in AI training (Reuters) Disclaimer: ● Initial 3 week subscription and 4 weeks of medication from $79 plus tax and $179 per month plus tax for 12 week subscription thereafter. Final pricing depends on program selection. ● Noom GLP-1Rx Program involves healthy diet, exercise and support. Individual results vary. Meds & personalization based on clinical need. Not reviewed by FDA for safety, efficacy, or quality. No affiliation with Novo Nordisk Inc., the only US source of FDA-approved semaglutide. Not available in all 50 US states ● Based on an analysis of self reported data from 1,254 engaged Noom users. Learn more about your ad choices. Visit megaphone.fm/adchoices

Tune in to the wildest late-night talk show on the airwaves, where the unexplained meets the absurd! Hosted by Walter Sterling, this podcast is a chaotic, highly entertaining mix of suppressed century-old medical cures, mind-bending UFO government cover-ups, and baffling mysteries like Havana Syndrome. Dive deep into massive conspiracies, including the "mud flood," the lost empire of Tartaria, and the theory that 1800s insane asylums were built to silence people who remembered giant humans. But it's not all high-strangeness—brace yourself for gritty true crime tales from retired NYPD cops, hilarious childhood nostalgia about front-yard moats and "fruit-only" fridges, bizarre "Florida Stories", and the secret "billion-dollar kiss" that saved Dawson's Creek. Buckle up for an unpredictable ride! Learn more about your ad choices. Visit megaphone.fm/adchoices

Vercel confirmed a breach traced to an AI platform's compromised OAuth app. The NSA is using Anthropic's Mythos despite the Pentagon blacklist. Mac Minis face 12-week wait times from AI agent demand, and humanoid robots crushed the Beijing half-marathon. Vercel says its internal systems were accessed after a Vercel employee's Google Workspace account was compromised via a breach at the AI platform Context.ai (BleepingComputer) Sources: the US NSA is using Mythos Preview; one source says Mythos is also being widely used within the DoD, despite Anthropic's supply chain risk designation (Axios) Adobe introduces CX Enterprise, an AI agent-based platform that aims to help corporate customers automate digital marketing and other functions (WSJ) Some Mac Mini and Mac Studio models are unavailable or facing up to 12-week wait times in the US, with analysts citing strong demand from AI agent power users (WSJ) Deezer says AI-generated tracks now account for 44% of daily uploads, totaling ~75K tracks per day and 2M+ per month, but account for just 1-3% of consumption (TechCrunch) Sources: Recursive Superintelligence, a four-month-old start-up developing self-teaching AI and founded by ex-DeepMind and OpenAI engineers, has raised $500M+ (FT) At the Beijing half-marathon, several humanoid robots beat human winners by 10+ minutes; a robot made by Honor beat the human world record held by Jacob Kiplimo (Reuters) Disclaimer: ● Initial 3 week subscription and 4 weeks of medication from $79 plus tax and $179 per month plus tax for 12 week subscription thereafter. Final pricing depends on program selection. ● Noom GLP-1Rx Program involves healthy diet, exercise and support. Individual results vary. Meds & personalization based on clinical need. Not reviewed by FDA for safety, efficacy, or quality. No affiliation with Novo Nordisk Inc., the only US source of FDA-approved semaglutide. Not available in all 50 US states ● Based on an analysis of self reported data from 1,254 engaged Noom users. Learn more about your ad choices. Visit megaphone.fm/adchoices

"Do I have to take these meds forever?" It's the most common question psychiatrists hear, but the answer is rarely a simple yes or no. In this episode, hosts Gabe Howard (living with bipolar) and Dr. Nicole Washington (board-certified psychiatrist) dive into the risks, the realities, and the honest conversations most doctors avoid when it comes to stopping bipolar medication. They break down why "cold turkey" is a recipe for disaster and explain the equally dangerous "hot turkey" otherwise known as restarting a full medication cocktail after a long break. Gabe shares his own journey of switching doctors to find a specialist in titration, illustrating the difference between "Mercedes Benz care" and trying to navigate a "hoopty" ride on your own. Dr. Nicole explains the science of brain receptors, the logistical hurdles of compounding pharmacies, and why the medical community is often resistant to "deprescribing." Listeners Will Learn: ·  Instead of "stopping" try reframing the conversation as "decreasing reliance" ·  Why lowering your medication slowly gives you better results ·  Finding a psych doctor who understands "deprescribing" may take time ·  A successful, safe medication adjustment can take a year or more—it is a marathon, not a sprint  Whether you're struggling with side effects like brain fog and sexual dysfunction or you simply want to feel more in control, this episode offers a roadmap for having an honest, data-driven conversation with your treatment team. Learn why "decreasing reliance" on medication is often a more successful goal than quitting entirely, and how to treat bumps in the road as data points rather than failures. "Most people think stopping meds is like flipping a light switch—on Monday you're on them, and on Tuesday you're not. But in reality, it's a slow, medical taper. It's more accurate to describe this as 'decreasing our reliance' rather than just quitting, so we can actually see what the data tells us." ~Gabe Howard, Host Our host, Gabe Howard, is an award-winning podcast host, author, and sought-after suicide prevention and mental health speaker, but he wouldn't be any of those things today if he hadn't been committed to a psychiatric hospital in 2003.Gabe also hosts Healthline's Inside Mental Health podcast has appeared in numerous publications, including Bipolar magazine, WebMD, Newsweek, and the Stanford Online Medical Journal. He has appeared on all four major TV networks, ABC, NBC, CBS, and FOX. Among his many awards, he is the recipient of Mental Health America's Norman Guitry Award, received two Webby Honoree acknowledgements, and received an official resolution from the Governor of Ohio naming him an “Everyday Hero.” Gabe wrote the popular book, "Mental Illness is an Asshole and other Observations," available from Amazon; signed copies are available directly from the author with free swag included! To learn more about Gabe, or to book him for your next event, please visit his website, gabehoward.com. Our host, Dr. Nicole Washington, is a native of Baton Rouge, Louisiana, where she attended Southern University and A&M College. After receiving her BS degree, she moved to Tulsa, Oklahoma to enroll in the Oklahoma State University College of Osteopathic Medicine. She completed a residency in psychiatry at the University of Oklahoma in Tulsa. Since completing her residency training, Dr. Nicole has spent most of her career caring for and being an advocate for those who are not typically consumers of mental health services, namely underserved communities, those with severe mental health conditions, and high performing professionals. Through her private practice, podcast, speaking, and writing, she seeks to provide education to decrease the stigma associated with psychiatric conditions. Find out more at DrNicolePsych.com. Tell a Friend: Sharing the show with the people we know is how our podcast will grow! Learn more about your ad choices. Visit megaphone.fm/adchoices

Send us Fan MailAI chatbots are everywhere now, and the real problem is not cheating or convenience. It is what happens to your brain when a tool offers a confident answer before you have wrestled with the evidence. We break down a fascinating study on generative AI and critical thinking that puts people in a city council scenario, forces a decision under time pressure, and tests how early versus late AI access changes argument quality, memory, and bias. The takeaway is practical for students, teachers, and anyone writing for work: timing matters, and “think first, then ask AI” is a stronger strategy than outsourcing the whole frame.Then we shift into pet science with a topic that hits right as spring arrives: flea and tick medication for dogs and cats. These antiparasitic drugs are effective, but new research suggests residues of common ingredients like isoxazoline can persist and enter the environment through pet waste. That raises uncomfortable questions about non-target insects, nutrient cycling, and the tradeoff between protecting our pets and protecting ecosystem health.Finally, volcanologist Dr. Sam Mitchell joins us for an Ask an Expert that moves from Antarctica to the ocean floor, where most of Earth's volcanic activity actually happens. We talk seafloor basalt, subduction zones, disaster movies worth watching, and the geology behind Olympic curling stones made from granite sourced on a tiny Scottish island. If you like science communication that connects daily life to big systems, this one is for you. Dr. Mitchell's LinksOur LinksAll our social links are here!Support the showFor Science, Empathy, and Cuteness!Being Kind is a Superpower.All our social links are here!

Send us Fan MailTrying to conceive can turn into a crash course in hormones overnight, and the medication list can feel like a different language. We slow it down and translate what fertility medications actually do in the body, why midwives still need to understand them even when we are not the prescribers, and how to support patients through the stress that often comes with IUI, IVF, and “why is this taking so long?” moments. We walk through the most common reason fertility care starts: ovulation problems. From anovulation and PCOS to the sometimes overlooked conversation about luteal phase length and early progesterone support, we talk about what might be happening on the HPO axis and what clinicians are trying to change with treatment. Then we break down the big names patients hear, including Clomid (clomiphene citrate) and letrozole (Femara), comparing how they work, what side effects to expect, and why practice has shifted toward letrozole for many people with PCOS and insulin-related hormonal patterns. We also dig into metformin and insulin resistance, because PCOS is not just “about weight” and fertility care should not be built on shame. Finally, we zoom out to the broader IVF medication lineup, including gonadotropin injections, GnRH agonist or antagonist protocols like Lupron, the hCG trigger shot, and progesterone support. We end with practical safety counseling, including multiples risk and ovarian hyperstimulation syndrome warning signs, plus clear guidance on when it is time to refer to reproductive endocrinology and infertility (REI). #FertilityMeds #PathToPregnancy #TTC #NavigatingFertility #PharmacologyForMidwives  #ConceptionSupport #ReproductiveEndocrinology #EvidenceBasedMidwifery #InfertilityCare

Send Us an Email to Chat!This week we deep dive into the 1992 stop motion horror flick Winterbeast! What the hell is this movie? What's going on this week? Gary Freestyles, David is on Meds! Shenanigans!Follow us on Instagram:@Gaspatchojones@Homewreckingwhore@The_Miseducation_of_DandG_Pod@QualityHoegramming@MullhollanddazeSupport the show

Netflix beat on revenue and income but dropped 10%+ on weak Q2 guidance as Reed Hastings exits the board. Anthropic launches Claude Design, OpenAI overhauls Codex Desktop with computer control, and DeepSeek seeks its first outside funding at $10B+. Netflix reports Q1 revenue up 16% YoY to $12.25B, vs. $12.2B est., net income up 83% YoY to $5.28B, and forecasts Q2 EPS and revenue below est.; NFLX drops 10%+ (Bloomberg) Anthropic launches Claude Design, a new experimental product that lets users create visuals like prototypes, slides, one-pagers, and more using Claude (TechCrunch) Sources: Dario Amodei is set to meet with WH Chief of Staff Susie Wiles on Friday, a breakthrough in Anthropic's effort to resolve its fight with the Pentagon (Axios) OpenAI updates its Codex desktop app with features like computer control, an in-app browser, image generation, automation memory, plugin support, and more (ZDNet) Sources: DeepSeek is in talks to raise outside capital for the first time, seeking at least $300M at a valuation of at least $10B (The Information) Longreads India produces 1.5M+ CS graduates annually, but AI coding tools are forcing its $315B IT outsourcing industry into an existential reckoning (Bloomberg) Doug Liman's $70M movie Bitcoin: Killing Satoshi uses AI for sets, lighting, and more in post-production, cutting costs from an estimated $300M (The Wrap) Defunct startups are being liquidated for their Slack archives, Jira tickets, and email threads—operational exhaust that AI labs now treat as premium training data (Forbes) Learn more at liquid.trade/techbrew. Disclaimer: ● Initial 3 week subscription and 4 weeks of medication from $79 plus tax and $179 per month plus tax for 12 week subscription thereafter. Final pricing depends on program selection. ● Noom GLP-1Rx Program involves healthy diet, exercise and support. Individual results vary. Meds & personalization based on clinical need. Not reviewed by FDA for safety, efficacy, or quality. No affiliation with Novo Nordisk Inc., the only US source of FDA-approved semaglutide. Not available in all 50 US states ● Based on an analysis of self reported data from 1,254 engaged Noom users. Learn more about your ad choices. Visit megaphone.fm/adchoices

Amazon's dropping $10.8 billion on Globalstar to beef up its Leo satellite network and challenge Starlink — and Apple's along for the ride. Plus, federal charges for the Sam Altman attacker, OpenAI acqui-hires a fintech startup, Google declares war on back button hijacking, data labeling startups are printing money, and Missouri voters revolt over a data center. Amazon agrees to acquire satellite operator Globalstar for $10.8B to expand Leo satellite network; Amazon and Apple say Leo will power some iPhone and Watch services (Amazon) Amazon to Acquire Globalstar in Satellite Cellular-Connection Push (WSJ) US DOJ charges Daniel Moreno-Gama, accused of throwing a Molotov cocktail at Sam Altman's home, with attempted murder and arson (CNN) Man who attacked OpenAI CEO's home had list of other AI executives (NYT) OpenAI acquires personal finance startup Hiro Finance (TechCrunch) Google designates "back button hijacking" as malicious, sites could be demoted in Search from June 15 (9to5Google) Data labeling startup Handshake's gross annualized revenue hits ~$1B; Mercor also at $1B+ pace (The Information) Voters in Festus, Missouri oust all four incumbent council members days after council approved a $6B data center (Politico) Learn more at liquid.trade/techbrew. Disclaimer: ● Initial 3 week subscription and 4 weeks of medication from $79 plus tax and $179 per month plus tax for 12 week subscription thereafter. Final pricing depends on program selection.● Noom GLP-1Rx Program involves healthy diet, exercise and support. Individual results vary. Meds & personalization based on clinical need. Not reviewed by FDA for safety, efficacy, or quality. No affiliation with Novo Nordisk Inc., the only US source of FDA-approved semaglutide. Not available in all 50 US states● Based on an analysis of self reported data from 1,254 engaged Noom users. Learn more about your ad choices. Visit megaphone.fm/adchoices

Are we turning to ADHD and depression medications too quickly for kids?The Wall Street Journal and New York Times recently published powerful investigations into the overuse of psychiatric medications in children. In this video, Dr. Bret Scher unpacks the key takeaways, the risks of polypharmacy, and why a comprehensive, root-cause approach is more important than ever for kids facing mental health challenges.

Episode 819: Neal and Toby recap the market moves since Trump announced a ceasefire with Iran. And, the New York Times claims they've narrowed down the true identity of Satoshi Nakamoto, the mysterious creator of Bitcoin. Also, Meta has entered the AI chat with its new homegrown AI model, Muse Spark. Then, it's Neal's Numbers on SF home prices, the average age of homes in the US, and why men are bad at shopping. Finally, it's a Master's preview! Learn more at taxact.com/business-returns Vote for our show for the Webby Awards: https://wbby.co/57452N  Subscribe to Morning Brew Daily for more of the news you need to start your day. Share the show with a friend, and leave us a review on your favorite podcast app. Listen to Morning Brew Daily Here:⁠ ⁠⁠https://www.swap.fm/l/mbd-note⁠⁠⁠  Watch Morning Brew Daily Here:⁠ ⁠⁠https://www.youtube.com/@MorningBrewDailyShow⁠ Noom full disclosure: When using Pricing HL: Initial 3 week subscription and 4 weeks of medication from $79 plus tax and $179 per month plus tax for 12 week subscription thereafter. Final pricing depends on program selection. When Microdose GLP-1 is mentioned: Noom GLP-1Rx Program involves healthy diet, exercise and support. Individual results vary. Meds & personalization based on clinical need. Not reviewed by FDA for safety, efficacy, or quality. No affiliation with Novo Nordisk Inc., the only US source of FDA-approved semaglutide. Not available in all 50 US states When 8lb weight loss claim used: Based on an analysis of self reported data from 1,254 engaged Noom users. Learn more about your ad choices. Visit megaphone.fm/adchoices

You've probably heard that medications like Ritalin, Adderall, or Vyvanse simply "fix" your attention. But what if I told you that most of what you think you know about how these meds work is actually wrong—or at least seriously incomplete? Understanding why neurodiversity is good for business starts with accurate information about how our brains actually function—including the real science behind ADHD medication.In this episode, we'll unpack new, game-changing scientific research that reveals what stimulants are truly doing in your brain. Spoiler: they're not just fixing your attention networks.We'll explore how these meds boost arousal and make boring business tasks feel more worth doing, why sleep is a critical performance variable, and what all of this means for structuring your workflows and managing your expectations as a business owner with ADHD.Whether you're taking medication, considering it, or just plain curious, this episode will help you understand the real role of stimulants in your entrepreneurial journey—and give you practical strategies to work with your brain.For years, we've been told stimulants “fix” our faulty attention networks. But new research out of Washington University just flipped that script—and it has huge implications for how we work, rest, and structure our businesses. This research on the attention mechanism in neural networks reveals that ADHD medication works differently than we thought.3 Key Takeaways:Stimulants = Wakefulness + Salience boost: They don't “fix” your attention span—they make your brain more awake (like a great night's sleep) and make boring tasks feel more worth doing.Sleep is a performance variable, not optional: Meds can mask sleep deprivation, but can't fix it. If you're hitting a wall by afternoon, it's likely a sleep issue, not a “bad brain” or “bad med” issue.Build your business around your real needs: Use your medicated hours for tedious-but-critical tasks, create systems that connect daily actions to meaningful outcomes, and get super-specific in conversations about what “isn't working”—the answer isn't always a higher dose.Resources Mentioned in the Episode: Study in Cell MagazineAbout the Host, Diann Wingert:Diann Wingert is the creator and host of ADHDish, a podcast that explores the realities of living with ADHD, especially for entrepreneurs and business owners. Rather than prescribing solutions, she empowers listeners to make informed choices, providing clear, actionable information in an approachable, no-nonsense style that makes her a trusted voice for those navigating ADHD in the workplace and beyond.Sharing is CaringKnow a fellow business owner who thinks their ADHD medication fixes their attention or claims they need a higher dose because it stopped working? They might need this wake-up call, too, so be a pal and share the episode. Here is a link to make it easy. Want one-on-one support? Ready to create the strategies that reduce the friction and fatigue of running a business with ADHD? Click here to book a free consultation. It's the first step to transforming what you're building intentionally through expert ADHD entrepreneur coaching.© 2026 ADHD-ish Podcast. Intro music by Ishan Dincer / Melody Loops / Outro music by Vladimir / Bobi Music / All rights reserved.

Aries are going through it right nowUse code BEACHTOOSANDY for an extra 30% off at blissy.com/beachtoosandy.Head to livemomentous.com, and use promo code BEACH for up to 35% off your first order.Try the AutoQuote Explorer® at progressive.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

You know how most things your conventional doctor tells you are wrong? Well, the same applies to your vet!

Today's Headlines: The Iran war's bill just got a lot bigger — the Pentagon is asking Congress for $200 billion, on top of the $12 billion already spent, while Trump insists he's "not putting troops anywhere" in a statement that inspired exactly zero confidence. Israel struck the South Pars Gas Field — the largest natural gas field in the world, shared by Iran and Qatar — damaging Qatari energy infrastructure, hitting an American F-35, and triggering retaliatory Iranian strikes across the region. Trump posted that the U.S. "knew nothing" about the attack, Israel immediately said that wasn't true, then Trump said he'd actually warned them not to do it — so he did know — and then threatened to blow up the entire gas field himself if Iran touches Qatar. Oil and gas prices climbed further, the stock market dropped, and seven allies — the UK, Japan, Germany, Italy, the Netherlands, Canada, and one more — announced they'd help reopen the Strait of Hormuz, which Trump accepted graciously by screaming in all caps that he doesn't need anyone's help. Also, Trump told Japan's prime minister "who knows better about surprise than Japan, why didn't you tell me about Pearl Harbor" — an actual thing he said out loud. Elsewhere in global chaos: Hungary's Viktor Orban blocked a $100 billion EU loan to Ukraine, potentially threatening the country's ability to keep its government running. Canada announced it's building its own sovereign space program to reduce dependence on Starlink. Two Iranian citizens were charged in the UK with spying on Jewish institutions on behalf of Iranian intelligence. And in one of the most cold-blooded moves yet, the U.S. State Department is reportedly considering withholding HIV medication from 1.3 million people in Zambia as leverage to extract a minerals deal — because apparently that's a negotiating tactic now. Markwayne Mullin's DHS nomination cleared committee 8-7, with Rand Paul voting no and John Fetterman voting yes, because nothing means anything anymore. Full Senate vote is next, outcome predictable. Resources/Articles mentioned in this episode: NYT: Pentagon Seeks Additional $200 Billion to Fund Iran War NYT: Israeli Officials Said U.S. Was Told About South Pars Attack Axios: After Tehran strikes, Trump says Israel won't attack Iran gas fields anymore Axios: Seven U.S. allies back potential Strait of Hormuz coalition NBC News: Trump makes Pearl Harbor joke during meeting with Japanese prime minister NYT: 2 Men Charged With Spying for Iran on Jewish Institutions in UK WSJ: Ukraine Suffers Money Setback After Hungary Blocks $100 Billion From Europe NYT: Canada Takes Its Sovereignty Push to Space NYT: U.S. Considers Withholding H.I.V. Aid Unless Zambia Expands Minerals Access AP News: Mullin's DHS nomination advances to full Senate despite opposition from Republican Rand Paul Subscribe to the Betches News Room and join the Morning Announcements group chat. Go to: ⁠⁠⁠betchesnews.substack.com Morning Announcements is produced by Sami Sage and edited by Grace Hernandez-Johnson Learn more about your ad choices. Visit megaphone.fm/adchoices

This week's stories: Smartphone App Catches What Sleep Trackers Miss A 2026 trial found that suvorexant, a popular prescription sleep drug, improves sleep quality scores — but worsens morning alertness and cognitive function while improving afternoon and evening performance. The study used a smartphone app to pulse users throughout the day, revealing a split-time-of-day signal that traditional sleep scales miss entirely. Optimizing your sleep dashboard and optimizing your waking performance are not the same thing. Sources: https://jamanetwork.com/journals/jama/fullarticle/suvorexant-ema-trial-2026 https://www.ncbi.nlm.nih.gov/pmc/articles/suvorexant-daytime-performance Bats Are Breaking the Telomere Model A 2026 bioRxiv preprint on the tropical bat species Molossus molossus found that these animals live unusually long lives with almost no telomere shortening — challenging the assumption that telomere erosion is a universal driver of mammalian aging. Instead, the bats maintain genome integrity through superior DNA repair and oxidative stress management driven by the metabolic demands of flight. Telomere length may be a symptom, not the cause — and the longevity industry has been measuring the wrong thing. Sources: https://www.biorxiv.org/content/molossus-molossus-telomere-longevity-2026 https://www.nature.com/articles/telomere-bat-aging-2026 The Fenugreek Hack That Cuts Glucose Spikes by Up to 20% Soaking fenugreek seeds overnight and consuming them before meals has been shown across multiple small human trials to reduce fasting glucose and post-meal glucose spikes by 5 to 20 percent. The mechanism is dual — soluble galactomannan fibers slow carbohydrate absorption while bioactive compounds improve insulin receptor sensitivity in muscle and liver. It's a cheap, food-grade, CGM-trackable lever that most people have never tried. Sources: https://www.ncbi.nlm.nih.gov/pmc/articles/fenugreek-glucose-clinical-review https://pubmed.ncbi.nlm.nih.gov/fenugreek-insulin-sensitivity-trial The First Longevity Supplement to Move Vascular Age Like Exercise A randomized, double-blind, placebo-controlled trial out of the University of Surrey found that a multi-ingredient longevity stack targeting NAD metabolism, glycation control, and mitochondrial function improved three independent vascular aging markers simultaneously in healthy adults over 40. Arterial stiffness improved by 1.18 meters per second — equivalent to reversing roughly a decade of age-related decline. Blood pressure dropped 6.1 millimeters of mercury, outperforming aerobic exercise, HIIT, the DASH diet, omega-3s, and magnesium in head-to-head comparisons. Sources: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=6241278 https://clinicaltrials.gov/study/NCT06145087 https://novoslabs.com/blog/supplements/novos-core-clinical-trial-results-longevity-supplement https://www.medicalnewstoday.com/articles/longevity-supplement-improves-vascular-aging-markers-clinical-trial-novos-magnesium-gi Carbon Monoxide Exposure Is Up 50% in 2026 — And Most People Won't Know Until It's Too Late Maryland state data reported by CBS News shows emergency room and urgent care visits for carbon monoxide exposure jumped from 167 cases in 2025 to 251 so far in 2026 — a nearly 50 percent increase. CO binds to hemoglobin more tightly than oxygen, quietly starving your brain, heart, and muscles while producing symptoms that mimic fatigue, brain fog, and the flu. The CDC estimates more than 400 Americans die from unintentional CO poisoning every year — and most of them never saw it coming. Sources: https://kffhealthnews.org/morning-briefing/friday-march-6-2026 https://www.cdc.gov/niosh/topics/co/default.html https://www.cbsnews.com/news/carbon-monoxide-exposure-maryland-spike-2026 Fat Plus Carbs Around Training May Actually Be the Metabolic Move A 2026 study found that combining fat with a carbohydrate-rich period during or around exercise improves insulin sensitivity and fat oxidation in the recovery phase — directly challenging the long-held "never stack fat and carbs" rule. The mechanism appears to be a mixed-fuel training effect: the liver and muscle learn to manage glucose and fat concurrently when both are present during high metabolic demand. Context changes the calculus, and the workout itself may be the variable that flips the equation. Sources: https://www.ncbi.nlm.nih.gov/pmc/articles/fat-carb-exercise-metabolism-2026 https://pubmed.ncbi.nlm.nih.gov/fat-carbohydrate-insulin-sensitivity-training All source links are provided for direct access to the original reporting and research. This episode is designed for biohackers, longevity seekers, and high-performance listeners who want mechanism-level clarity on circadian biology, neurodegeneration signals, cognitive training, caffeine strategy, and supplement regulation. Host Dave Asprey connects emerging science, behavioral data, and policy shifts into practical frameworks you can use to build a resilient, adaptable health stack. New episodes every Tuesday, Thursday, Friday, and Sunday. Keywords: sleep medication daytime performance, suvorexant alertness, sleep score vs performance, telomere aging myth, bat longevity telomeres, DNA repair aging, fenugreek blood glucose, fenugreek insulin sensitivity, CGM glucose hack, longevity supplement clinical trial, vascular aging markers, arterial stiffness reversal, pulse wave velocity supplement, carbon monoxide poisoning 2026, CO detector home safety, environmental toxin biohacking, fat and carbs exercise, macronutrient timing training, insulin sensitivity workout, metabolic flexibility training, biohacking news, longevity research 2026 Thank you to our sponsors! - The One Device | Use code DAVE for $10 off at theonedevice.com/dave - Screenfit | Get your at-home eye training program for 40% off using code DAVE at https://www.screenfit.com/dave. Resources: • Get My 2026 Clean Nicotine Roadmap | Enroll for free at https://daveasprey.com/2026-clean-nicotine-roadmap/ • Get My 2026 Biohacking Trends Report: https://daveasprey.com/2026-biohacking-trends-report/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Join My Substack (Live Access To Podcast Recordings): https://substack.daveasprey.com/ • Upgrade Labs: https://upgradelabs.com Timestamps: 00:00 – Intro 00:20 – Trailer 00:57 - Story #1: Sleep Meds & Morning Performance 02:42 - Story #2: Bats & the Telomere Model 04:33 - Story #3: Fenugreek & Glucose Spikes 06:00 - Story #4: Multi-Ingredient Longevity Stack Trial 07:51 - Story #5: Carbon Monoxide: The Silent Threat 09:45 - Story #6: Fat + Carbs Around Exercise 11:25 - Weekly Roundup See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Of course someone with ADHD forgot their ADHD medication. In this episode, we're getting into the beautifully ironic disaster of leaving your ADHD pills at home and only realizing it once you're hundreds of miles away, about to spend four days walking backwards across college campuses while your daughter decides her future.We're talking about what those days actually feel like without your medication: the brain fog, the overstimulation, the trying-to-read-a-campus-map-while-someone-is-talking-to-you experience. And the reality of living with ADHD.And underneath all of it the pressure of wanting to be locked in and fully present for your daughter during a trip that actually matters.Spoiler: you survived. And it might have even been a little funny in retrospect.A story about ADHD, road trips, and showing up for your kid even when your brain has left the building. Hosted on Acast. See acast.com/privacy for more information.

Your sister went off her meds, fled cops, got in a bar fight, and assaulted an officer. Now she faces felonies and won't let you help. It's Feedback Friday!And in case you didn't already know it, Jordan Harbinger (@JordanHarbinger) and Gabriel Mizrahi (@GabeMizrahi) banter and take your comments and questions for Feedback Friday right here every week! If you want us to answer your question, register your feedback, or tell your story on one of our upcoming weekly Feedback Friday episodes, drop us a line at friday@jordanharbinger.com. Now let's dive in!Full show notes and resources can be found here: jordanharbinger.com/1294On This Week's Feedback Friday:Your sister with schizoaffective disorder went off her meds, quit her job, led cops on a chase, started a bar fight, and injured an officer — and now she's facing felony charges while refusing your help and rejecting her own public defender. How do you save someone who won't be saved?You're pretty sure your wife's business partners are hiding financials, breaching the partnership agreement, and planning to retire while still collecting profits she earns — but she's terrified of "being mean." How do you help her find her backbone before they bleed her dry?Your selfless 69-year-old mom is being run ragged by your sister-in-law's marathon visits — nine-hour affairs with free meals, free babysitting, and zero cleanup — and she's too kind to say a word. She even quit her fitness class. How do you protect a woman who won't protect herself?Recommendation of the Week: Gabe recommends keeping a quick daily travel log in your phone's notes app and pinning your favorite spots on a custom Google Maps list so you can relive your trips more vividly — and share killer recs with friends headed to the same destinations.Your six-year-old son had a helmet-throwing meltdown at Little League, and now three families — including an assistant coach — have requested he not be on their team. You practiced an apology that never happened, and Opening Day is coming. How do you handle the awkward reunion?Have any questions, comments, or stories you'd like to share with us? Drop us a line at friday@jordanharbinger.com!Connect with Jordan on Twitter at @JordanHarbinger and Instagram at @jordanharbinger.Connect with Gabriel on Twitter at @GabeMizrahi and Instagram @gabrielmizrahi.And if you're still game to support us, please leave a review here — even one sentence helps! Sign up for Six-Minute Networking — our free networking and relationship development mini course — at jordanharbinger.com/course!Subscribe to our once-a-week Wee Bit Wiser newsletter today and start filling your Wednesdays with wisdom!Do you even Reddit, bro? Join us at r/JordanHarbinger!This Episode Is Brought To You By Our Fine Sponsors: Mint Mobile: Shop plans at mintmobile.com/jhsAudible: Visit audible.com/jhs or text JHS to 500-500Quiltmind: Email jordanaudience@quiltmind.com to get started or visit quiltmind.com for more infoThe President's Daily Brief: Listen here or wherever you find fine podcasts!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.